NEW YORK (GenomeWeb News) – Turku, Finland-based VTT today said that it is collaborating with Roche on research studies for an unnamed Roche cancer drug and potential predictive biomarkers.
 
VTT said the studies will use its high-throughput screening, RNA interference, cell biology, and bioinformatics capabilities. The firm said it would conduct the research at its facilities in Finland.
 
Terms of the alliance were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.